Improving acute care for people with Alzheimer's disease and related dementias
Official title: Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
Funded at Dartmouth College · NIH-11400365 · Data updated 2026-11-12
This project looks at how people with Alzheimer’s and related dementias are diagnosed and treated when they have sudden illnesses like blood clots or heart attacks.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dartmouth College NIH-funded |
| Lab location | 1 site (Hanover, United States) |
| Project start | August 1, 2001 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $282,254 |
| NIH project number | 5P01AG019783-24 |
| Project ID | NIH-11400365 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults diagnosed with Alzheimer's disease or related dementias who experience acute illnesses such as pulmonary embolism or acute myocardial infarction.
✕Less likely to help
Patients without ADRD or those not experiencing acute illnesses like PE or AMI.
What this research studies
If you have ADRD, your symptoms and ability to communicate may change how doctors decide which tests and treatments you should get during acute illnesses. The project studies whether having ADRD affects the likelihood of receiving certain diagnostic tests and more intensive treatments for conditions like pulmonary embolism and heart attack. It also works to create a hospital-wide measure of how testing and diagnostic processes are used for these patients. The goal is to identify gaps and improve decision-making to ensure safer, more appropriate care for ADRD patients in acute settings.
Why it matters
Potential benefit: Findings could lead to better, more personalized emergency care for people with ADRD.
How similar studies have gone: Previous work suggests that cognitive impairment can influence testing and treatment decisions, but this project seeks to systematically quantify and improve those processes.
Where this research is happening
-
Dartmouth College
Hanover, United States Active
Researchers
- Principal investigator: Agha, Leila S. — Dartmouth College
- Study coordinator: Agha, Leila S.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.